Researchers at Rutgers University are using X-ray crystallography, a technique to determine the structure of molecules, to develop drugs that target a key submicroscopic protein in HIV. Dr. Smith said, “If you can really inhibit reverse transcriptase, you can stop AIDS.” Researchers are optimistic about a new class of RT inhibitors, including a drug known as R278474. It interfers with an enzyme that the virus needs to copy and insert itself into a human cell.

via The Globe and Mail